Key result
Abstract reports no specific findings on vascular access and complications in COVID-19 versus non-COVID-19 ARDS.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Vascular access decisions in ARDS should remain etiology-agnostic; Level 5 comparison leaves open differential complication risks.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bzeih et al. (2021) studied this question. COVID-19 ARDS and non-COVID-19 ARDS patients were compared for vascular access and complications, but specific findings are not available in the provided abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: